SCHEMBL3719007

SCHEMBL3719007

COc1ccc(Oc2ccc(CNC(=O)C3(NC(=O)c4cnc(Cl)s4)CC3)nc2)c(C(F)(F)F)c1

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
EPHX2 P34913 8/20 0.36
MAPK10 P53779 2/20 0.35
MAPK8 P45983 1/20 0.35
BDKRB1 P46663 1/20 0.35
CNR2 P34972 2/20 0.34
CNR1 P21554 1/20 0.34
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13191262 0.89 RORC (0.33) P2RX7MEN1KMT2ANPSR1BDKRB1
SCHEMBL13191701 0.88 KMT2A (0.38) P2RX7MEN1KMT2ANPSR1EPHX2
SCHEMBL13191622 0.88 EPHX2 (0.47) P2RX7MEN1KMT2AEPHX2BDKRB1
SCHEMBL13191624 0.87 EPHX2 (0.40) P2RX7EPHX2BDKRB1
SCHEMBL3718251 0.87 P2RX7 (0.39) P2RX7MEN1KMT2ANPSR1EPHX2
SCHEMBL13191616 0.86 P2RX7 (0.38) P2RX7EPHX2BDKRB1
SCHEMBL3722271 0.86 BDKRB1 (0.43) P2RX7EPHX2BDKRB1CNR1
SCHEMBL13191647 0.86 P2RX7 (0.37) P2RX7MEN1KMT2ANPSR1EPHX2
SCHEMBL13191237 0.86 RAB9A (0.40) P2RX7EPHX2BDKRB1
SCHEMBL13191643 0.86 P2RX7 (0.39) P2RX7KMT2AEPHX2BDKRB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed